Physicians' Education Resource^®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource^®, LLC designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource^®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 2.0 Contact Hours.

Resources

PER Pulse™ Recap
from the 20th Annual International Congress on Hematologic Malignancies^® focuses on multiple myeloma (MM), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).

Acknowledgment of Commercial Support

This activity is supported by educational grants from AbbVie; Ariad Pharmaceuticals, Inc; Baxalta US Inc; Bristol-Myers Squibb; Celgene; Genentech, Inc; Gilead; Incyte Corporation; Infinity Pharmaceuticals, Inc; Novartis Pharmaceuticals Corporation; Pharmacyclics LLC and Janssen Biotech, Inc; Seattle Genetics; Takeda Oncology; and TG Therapeutics, Inc.

Community Practice Connections™: 20th Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and Myeloma

Release Date: May 24, 2016
Expiration Date: May 24, 2017
Media: Internet - based

Activity Overview

Community Practice Connections™: 20th Annual International Congress on Hematologic Malignancies^®: Focus on Leukemias, Lymphomas and Myeloma consists of a series of interactive clinical vignettes, short video interviews of leading experts in hematologic malignancies, and short summaries of clinical data related to these issues. The video interviews address decision points in the clinical vignettes, as well as questions commonly faced in the community oncology practice setting.

CME Activity Table of Contents

A Patient With Chronic Lymphocytic Leukemia
A Patient With Diffuse Large B-Cell Lymphoma
A Patient With Newly Diagnosed Multiple Myeloma
An Elderly Patient With Acute Myeloid Leukemia

Instructions For This Activity & Receiving Credit

You will need to login to participate in the activity.
Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
At the end of the activity, "educational content/video" will be available for your reference.
In order to receive a CME/CE certificate, participants must complete the activity.
Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a CME/CE certificate upon completion of these steps.

Target Audience

This educational activity is directed toward community-based hematologists and medical oncologists, as well as fellows involved in the treatment and management of patients with hematologic malignancies. Nurse practitioners (NPs), nurses, physician assistants (PAs), pharmacists, researchers, and other healthcare professionals interested in the treatment of hematologic malignancies may also participate.

Educational Objectives

At the conclusion of this activity, you should be better prepared to:

Describe current and evolving genomic and molecular biomarkers that can be used to stratify risk and inform clinical decision making in the management of hematologic malignancies
Assess landmark clinical trial results in the context of how they impact evolving clinical practice paradigms and can be applied to personalize care and optimize outcomes
Delineate effective strategies to proactively mitigate and manage predictable side effects related to the management of hematologic malignancies so that treatment outcomes can be maximized
Evaluate recent clinical trial findings concerning novel compounds or strategies to manage hematologic malignancies
Consider the therapeutic implications of emerging data on evolving treatment paradigms for patients with hematologic tumors

Faculty, Staff, and Planners' Disclosures

Faculty

Andre Goy, MD, MS
Chairman and Director, Chief of Lymphoma
Director, Clinical and Translational Cancer Research
John Theurer Cancer Center at Hackensack University Medical Center
Professor of Medicine, Georgetown University
Hackensack, NJ

Elias Jabbour, MD
Associate Professor, Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, TX

Sagar Lonial, MD, FACP
Professor, Emory School of Medicine
Chair, Department of Hematology & Medical Oncology
Chief Medical Officer
Winship Cancer Institute of Emory University
Atlanta, GA

Susan O'Brien, MD
Associate Director for Clinical Science
Medical Director of the Sue and Ralph Stern Center
for Cancer Clinical Trials and Research
Chao Family Comprehensive Cancer Center
University of California, Irvine
Irvine, CA

The following individuals have no relevant financial relationships with commercial interests to disclose:

Elias Jabbour, MD, and the staff of Physicians' Education Resource^®, LLC.

The following individuals have relevant financial relationships with commercial interests to disclose:

Andre Goy, MD, MS -- Grant/Research Support: JNJ, Celgene -- clinical trial support through institution; Consultant: Celgene; Speaker's Bureau: Takeda; JNJ/Pharmacyclics; Other: Member on Advisory Board: Celgene, Takeda, Pharmacyclics, JNJ; Sagar Lonial, MD, FACP -- Consultant: Novartis, Onyx, Millennium, BMS, Sanofi, Celgene, Janssen; Susan M. O'Brien, MD -- Grant/Research Support: Acerta Pharma, TG Therapeutics, Regeneron, Gilead Sciences, Pharmacylics, ProNAi Therapeutics; Consultant: Amgen, Celgene.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

It is the policy of Physicians' Education Resource^®, LLC, (PER^®) to ensure fair balance, independence, objectivity, and scientific rigor in all of our CME/CE activities. In accordance with ACCME guidelines, PER^® requires everyone who is in a position to control the content of an educational activity, including spouses/partners, to disclose all relevant financial relationships with any commercial interest to participants as a part of the activity planning process. PER^® has implemented mechanisms to identify and resolve all conflicts of interest prior to release of this activity.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label uses of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical education purposes only, and is not meant to substitute for the independent medical judgment of a physician or nurse relative to diagnostic, treatment, or management options for a specific patient's medical condition.

The opinions expressed in the content are solely those of the individual faculty members, and do not reflect those of Physicians' Education Resource^®, LLC, or any of the companies that provided commercial support for this activity.

Hardware And Software Requirements

Supported Browsers
Internet Explorer v.7 or greater (for Windows) | Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)

Minimum System Requirements (Windows)